Mandiri Capital Indonesia

Corporate VC Jakarta, Indonesia · Founded 2015

The corporate venture arm of Bank Mandiri, aggressively funding specialized technology and fintech/health-tech integration.

About Mandiri Capital Indonesia

Mandiri Capital Indonesia is the corporate venture arm of Bank Mandiri, one of Indonesia’s largest commercial banks, headquartered in Jakarta. The fund writes Series A and Series B checks in the $1M to $5M range, with a strategic focus on fintech and the integration of financial services with adjacent verticals including health-tech. The healthcare interest is concentrated in digital health where the business model intersects with payments, insurance, embedded finance, or other Bank Mandiri product lines, and the firm is not positioned as an AI-native specialist. Because Mandiri Capital is a strategic CVC tied to a major Indonesian bank, the investment logic prioritizes companies whose distribution, customer base, or product integration creates material value for Bank Mandiri’s commercial banking, retail banking, or payments platforms. The geographic focus is Indonesia with selective Southeast Asian expansion. The right founder profile is a Series A-ready digital health founder with a clear thesis on how integration with Bank Mandiri’s customer base, payments rails, or insurance distribution accelerates scale, ideally with an angle around health insurance, healthcare payments, or financing of out-of-pocket health spending. The wrong fit is a deep-tech biotech, a research-stage AI platform, or a healthcare business with no financial-services connection; the strategic logic is the entire point. The right entry path is through Jakarta corporate-development networks, through Bank Mandiri’s broader institutional ecosystem, and through warm introductions from co-investors at firms like East Ventures, Alpha JWC, and Insignia Ventures Partners. When pitching, lead with the strategic fit to Bank Mandiri’s commercial logic and quantify the partnership value, then connect to the standalone commercial trajectory of your healthtech business. Avoid generic regional decks. Caveats: as with any bank CVC, regulatory considerations around the parent’s banking licenses can constrain how the strategic relationship is structured, and founders should manage exclusivity and information rights deliberately. Use Mandiri Capital Indonesia when Bank Mandiri integration is genuinely accretive to your digital health business, not as a generic Indonesian check.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Other portfolio companies

Companies in Mandiri Capital Indonesia's portfolio not currently in our directory.

  • FitAja Digital Nusantara
  • Cakap
  • AgriAku
  • Amartha
  • Ayoconnect

Team

Ronald Simorangkir
Chief Executive Officer

Pitch / review this investor

Have you raised from Mandiri Capital Indonesia? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.